Crystal Proud
Neurology with Special Qualifications in Child Neurology · Norfolk, VANPI 1013159177
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $663,626 of the $1,001,986 with a category attached, or 66.2%. Sarepta Therapeutics, Inc. accounts for 61.2% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $279,590, 3.3 times the $85,861 reported in 2019. Among neurology with special qualifications in child neurology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 854 payments — averaging $1173.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$613K
- Biogen$263K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$68K
- F. Hoffmann-la Roche AG$22K
- Genentech USA, Inc.$10K
- Hoffmann-la Roche Limited$10K
- plus $17K from 12 others
Across 1,475 payments — averaging $4153.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sarepta Therapeutics, Inc.$3.9M
- Novartis$724K
- Biogen$626K
- CSL Behring$445K
- PTC Therapeutics, Inc.$101K
- Vertex$96K
- plus $275K from 8 others
What the payments were for
- Consulting fees$663,62666%
- Speaking & faculty fees$226,93223%
- Travel & lodging$78,8998%
- Food & beverage$24,0752%
- Education$8,4541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 254 | $612,934 |
| Biogen | 435 | $262,551 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 95 | $68,287 |
| F. Hoffmann-la Roche AG | 9 | $21,752 |
| Genentech USA, Inc. | 9 | $9,805 |
| Hoffmann-la Roche Limited | 6 | $9,656 |
| Pfizer | 6 | $8,358 |
| ITF Therapeutics LLC | 11 | $5,044 |
| Novartis | 5 | $2,581 |
| Supernus Pharmaceuticals, Inc. | 8 | $336 |
| Novartis Pharma AG | 1 | $175 |
| PTC Therapeutics, Inc. | 2 | $149 |
| Genentech, Inc. | 2 | $96 |
| Insmed, Inc. | 2 | $84 |
| Livanova USA, Inc. | 4 | $81 |
| Catalyst Pharmaceuticals, Inc. | 3 | $72 |
| Advanced Respiratory, Inc | 1 | $24 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,001,986 in reported general payments places this provider in the 95th percentile of 23 neurology with special qualifications in child neurology providers in Virginia.
See all neurology with special qualifications in child neurology providers in Virginia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EvrysdiRisdiplam | 11 | $289,640 |
| Fluoxetine Hcl | 13 | $126 |
| Prednisone | 13 | $68 |
| Baclofen | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Genentech USA, Inc.Evrysdi | $9,805 | $289,64011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 23 neurology with special qualifications in child neurology providers in Virginia.
Other neurology with special qualifications in child neurology in Norfolk
- Michael StruncNorfolk$639K
- Ryan WilliamsNorfolk$4K
- Georg DahlNorfolk$2K
- Ralph NorthamNorfolk$2K
- Ludwig FrankNorfolk$1K
- Svinder ToorNorfolk$139
- Mathula ThangarajhRichmond$47K
- Amy HarperRichmond$46K
- Lawrence MortonRichmond$17K
- Alison AlfordRichmond$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.